Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)
Ikuo Fukuda, Takanori Hayasaki, Kazufumi Hirano(Netherlands Pharmacovigilance Centre Lareb), Tsubasa Tajima(Bay Medical Center), Mashio Nakamura, Norifumi Nakanishi(National Cerebral and Cardiovascular Center), Takao Kobayashi(Hokkaido University), Toshiyuki Sunaya(Health Data Research UK), Yutaka Okayama(Netherlands Pharmacovigilance Centre Lareb), Sanghun Iwashiro(Bayer (Japan)), Norikazu Yamada(Tohoku University), Atsushi Hirayama(Nihon University), Hideaki Maeda(Nihon University), Kazuo Kawasugi(Teikyo University)
Cited by 2
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|552
The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
|The Journal of Immunology|2011|490
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404